J 2010

Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period

ČERMÁK, Aleš, Natália MAREČKOVÁ, Kamila KARMAŠOVÁ a Dalibor PACÍK

Základní údaje

Originální název

Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period

Název anglicky

Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period

Autoři

ČERMÁK, Aleš (203 Česká republika, garant, domácí), Natália MAREČKOVÁ (703 Slovensko, domácí), Kamila KARMAŠOVÁ (203 Česká republika, domácí) a Dalibor PACÍK (203 Česká republika, domácí)

Vydání

European Urology Supplements, Elsevier B.V. 2010, 1569-9056

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.139

Kód RIV

RIV/00216224:14110/10:00046964

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

prostate cancer infectious complications antibiotic therapy antibiotic resistence
Změněno: 19. 1. 2011 21:54, MUDr. Vítězslav Vít

Anotace

V originále

The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).

Anglicky

The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).